Drug Injury Watch: Pradaxa Adverse Drug Events (ADEs) Result In Death More Often Than Other Anticoag
Drug Injury Watch: Pradaxa Adverse Drug Events (ADEs) Result In Death More Often Than Other Anticoagululants / Blood Thinners ADE Reports Again In 2012, Pradaxa (Dabigatran) Had Dubious Distinction Of Being Ranked First For Direct FDA Reports Of Adverse Events http://www.drug-injury.com/druginjurycom/2013/10/pradaxa-hemorrhage-severe-bleeding-adverse-drug-events-deaths-fda-reports-anticoagululants-blood-thinners.html
Contributor
About
I have a national litigation practice based in Wilmington, North Carolina, representing people who have cases involving prescription drug injury lawsuits and asbestos-mesothelioma claims.
I have a national litigation practice based in Wilmington, North Carolina, representing people who have cases involving prescription drug injury lawsuits and asbestos-mesothelioma claims.
Related Documents in Personal Injury
- Drug Injury Watch: Is Plavix-Related Hemophilia Side Effect Significant Enough For Label Change In E
- Drug Injury Watch: October 2013 NuvaRing Label Change: Warnings And Precautions Section Sets Forth T
- Drug Injury Watch: Flomax Can Cause Severe Hypotension According To A New Medical Study Article Publ
Categories
- Articles 313
- Bankruptcy 44
- Business 135
- Cases & Codes 68
- Contracts 27
- Criminal Law 122
- Employment 24
- Expert Reports 3
- Expert Witness 34
- Family Law 58
- Form Letters 15
- Immigration 3
- Intellectual Prop 32
- Internet Law 10
- Law Practice 99
- Law School 2
- Legal Research 19
- Litigation 186
- Miscellaneous 64
- PR Web 41689
- Personal Injury 609
- Press Release 43
- Probate 54
- Real Estate 68
- Tax Law 23
- Workers Comp 4